Core Alternative Capital’s DexCom DXCM Stock Holding History

Core Alternative Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20	Closed	-$1.35K	–	253
2025 Q3	$1.35K	Sell	20 -2	-9%	-$158	﹤0.01%	277
2025 Q2	$1.92K	Hold	22	–	–	﹤0.01%	242
2025 Q1	$1.5K	Hold	22	–	–	﹤0.01%	253
2024 Q4	$1.71K	Hold	22	–	–	﹤0.01%	273
2024 Q3	$1.48K	Hold	22	–	–	﹤0.01%	287
2024 Q2	$2.49K	Hold	22	–	–	﹤0.01%	252
2024 Q1	$3.05K	Sell	22 -130	-86%	-$16.3K	﹤0.01%	241
2023 Q4	$18.9K	Sell	152 -514	-77%	-$52.5K	﹤0.01%	228
2023 Q3	$62.1K	Buy	666 +442	+197%	+$49.8K	0.01%	173
2023 Q2	$28.8K	Sell	224 -158	-41%	-$19.1K	﹤0.01%	190
2023 Q1	$44.4K	Buy	382 +194	+103%	+$21.7K	0.01%	169
2022 Q4	$21.3K	Sell	188 -120	-39%	-$13.2K	﹤0.01%	212
2022 Q3	$25K	Hold	308	–	–	﹤0.01%	199
2022 Q2	$23K	Buy	308 +160	+108%	+$14.6K	0.01%	208
2022 Q1	$19K	Buy	148 +96	+185%	+$10.5K	0.01%	219
2021 Q4	$7K	Buy	+52	New	+$7.47K	﹤0.01%	159

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Core Alternative Capital's DXCM Position: Q4 2025 in Review

Core Alternative Capital sold out of DexCom (DXCM) in Q4 2025, closing a stake of 20 shares — an estimated $1.35K sold.

Core Alternative Capital first reported a position in DXCM in Q4 2021 and held it in 16 quarters. The position peaked at $62.1K in Q3 2023. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Core Alternative Capital reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Core Alternative Capital sold 20 DexCom shares in Q4 2025, an estimated $1.35K.
Core Alternative Capital first reported a position in DexCom in Q4 2021 and held it in 16 quarters.
Core Alternative Capital's DexCom position peaked at $62.1K in Q3 2023.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Core Alternative Capital's 13F filing for Q4 2025, filed 2 Feb 2026.